Replies to post #201811 on NorthWest Biotherapeutics Inc (NWBO)

[doingmybest]

There are other factors as well. When you compare these products you have to look at the entire data package available to be shared, whether the product is in addition to SOC or in place of it, which changes the complexity of the data interpretation, and, whether the technology is new and considered revolutionary and thereby attracting more competitive attention. Keep in mind DC therapy has been severely discounted in the market due to Provenge, though it was a breakthrough discovery, it relegated the perspective of the technology to a second tier until and when better performance is proven.